© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
October 10, 2016
While estrogen therapy may not be the best option for all women in menopause, there is an effort underway to help educate patients and providers alike as to how best to approach this topic to provide the best results possible.
There are several products on the market designed to help patients manage the symptoms associated with menopause. New research was recently presented on one option which does not include progesterone and what that means for care.
October 08, 2016
At The North American Menopause Society 27th Annual Meeting (NAMS) in Orlando, Florida, Janet Carpenter, PhD, RN, Indiana University discussed her latest research in nonhomonal alternatives for women experiencing hot flashes including a clinical hypnosis protocol.
At The North American Menopause Society 27th Annual meeting (NAMS), Holly Thomas, MD, MS, University of Pittsburgh, discussed her program of research mainly focuses on how sex changes for women as they move through midlife and into older age.
At The North American Menopause Society 27th Annual Meeting (NAMS), Rebecca Thurston, PhD, University of Pittsburgh, discussed her research on the relationship between sleep and cardiovascular disease in menopause patients.
October 07, 2016
As Peter Schnatz, DO, Reading Health System, completes his term as President of NAMS, he reflected on the initial goals he'd had before assuming his position. His primary initiative was to bring the best care they could to menopausal women. Schnatz said they'd been working really hard on reopening the conversation of the use and utilization of hormonal therapy.
Peter Schnatz, DO, Reading Health System, current President of The North American Menopause Society (NAMS), spoke about his presidential address, which discussed breast arterial calcification (BAC) and the association with risk factors and atheroscleratic cardiovascular disease.
There is limited data in this population, but some research says that women shouldn't be starting the therapy after the age of 60. However, hormone therapies offer bone protection, which opens the door discussion on usage.
Hadine, Joffe, MD, MSc, explained at The North American Menopause Society 27th Annual Meeting (NAMS), that their research validates there's a biological basis for these symptoms and that these are the brains' responses to hormone changes and the symptom manifestations of those hormone changes.
At The North American Menopause Society 27th Annual Meeting (NAMS), Hadine Joffe, MD, MSc, Brigham and Women's Hospital explained that she always has her patients use sleep hygiene, and that there are some really key strategies that has no side effects.
Adults in US with Vision Impairment Reported Lower Access to Health Care Services
PRA023 Showing Promise in Both Crohn’s Disease, Ulcerative Colitis
Why Health Care Was Unprepared for the 2022 RSV Surge